Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma.
Rosati G, Ambrosini G, Barni S, Andreoni B, Corradini G, Luchena G, Daniele B, Gaion F, Oliverio G, Duro M, Martignoni G, Pinna N, Sozzi P, Pancera G, Solina G, Pavia G, Pignata S, Johnson F, Labianca R, Apolone G, Zaniboni A, Monteforte M, Negri E, Torri V, Mosconi P, Fossati R; GILDA working group. Rosati G, et al. Among authors: duro m. Ann Oncol. 2016 Feb;27(2):274-80. doi: 10.1093/annonc/mdv541. Epub 2015 Nov 16. Ann Oncol. 2016. PMID: 26578734 Free article. Clinical Trial.
High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.
Labianca R, Cascinu S, Frontini L, Barni S, Fiorentini G, Comella G, Zaniboni A, Gottardi O, Arnoldi E, Oliani C, Duro M, Pavanato G, Martignoni G, Raina A, Piazza E, Dallavalle G, Valsecchi R, Pancera G, Luporini G. Labianca R, et al. Among authors: duro m. Ann Oncol. 1997 Feb;8(2):169-74. doi: 10.1023/a:1008200713533. Ann Oncol. 1997. PMID: 9093726 Free article. Clinical Trial.
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract Cancer.
Labianca R, Giaccon G, Barni S, Ambrosini G, Iirillo A, Fiorentini G, Duro M, Piazza E, Oliani C, Pancera G, et al. Labianca R, et al. Among authors: duro m. Eur J Cancer. 1994;30A(11):1611-6. doi: 10.1016/0959-8049(94)00190-g. Eur J Cancer. 1994. PMID: 7833131 Clinical Trial.
Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis.
Fagnani D, Franchi R, Porta C, Pugliese P, Borgonovo K, Bertolini A, Duro M, Ardizzoia A, Filipazzi V, Isa L, Vergani C, Milani M, Cimminiello C; POLONORD Group. Fagnani D, et al. Among authors: duro m. Ann Oncol. 2007 Mar;18(3):551-5. doi: 10.1093/annonc/mdl431. Epub 2006 Dec 8. Ann Oncol. 2007. PMID: 17158773 Free article. Clinical Trial.
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Pusceddu S, Vernieri C, Di Maio M, Marconcini R, Spada F, Massironi S, Ibrahim T, Brizzi MP, Campana D, Faggiano A, Giuffrida D, Rinzivillo M, Cingarlini S, Aroldi F, Antonuzzo L, Berardi R, Catena L, De Divitiis C, Ermacora P, Perfetti V, Fontana A, Razzore P, Carnaghi C, Davì MV, Cauchi C, Duro M, Ricci S, Fazio N, Cavalcoli F, Bongiovanni A, La Salvia A, Brighi N, Colao A, Puliafito I, Panzuto F, Ortolani S, Zaniboni A, Di Costanzo F, Torniai M, Bajetta E, Tafuto S, Garattini SK, Femia D, Prinzi N, Concas L, Lo Russo G, Milione M, Giacomelli L, Buzzoni R, Delle Fave G, Mazzaferro V, de Braud F. Pusceddu S, et al. Among authors: duro m. Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13. Gastroenterology. 2018. PMID: 29655834 Free article.
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.
Fagnani D, Bertolini A, Catena L, Tomirotti M, Visini M, Alatri A, De Paoli A, Aondio GM, Milani M, Arpaia G, Cimminiello C; POLONORD Group; Franchi R, Porta C, Pugliese P, Borgonovo K, Duro M, Ardizzoia A, Filipazzi V, Isa L, Vergani C, Carpenedo M, Viale P. Fagnani D, et al. Among authors: duro m. Blood Coagul Fibrinolysis. 2009 Jan;20(1):35-40. doi: 10.1097/MBC.0b013e32831bc2f8. Blood Coagul Fibrinolysis. 2009. PMID: 20523163
Effects of APOE4 on omega-3 brain metabolism across the lifespan.
Ebright B, Duro MV, Chen K, Louie S, Yassine HN. Ebright B, et al. Among authors: duro mv. Trends Endocrinol Metab. 2024 Apr 11:S1043-2760(24)00065-1. doi: 10.1016/j.tem.2024.03.003. Online ahead of print. Trends Endocrinol Metab. 2024. PMID: 38609814 Review.
Synthesis and Preclinical Evaluation of 22-[18F]Fluorodocosahexaenoic Acid as a Positron Emission Tomography Probe for Monitoring Brain Docosahexaenoic Acid Uptake Kinetics.
Duro MVV, Van Valkenburgh J, Ingles DE, Tran J, Cai Z, Ebright B, Wang S, Kerman BE, Galvan J, Hwang SH, Sta Maria NS, Zanderigo F, Croteau E, Cunnane SC, Rapoport SI, Louie SG, Jacobs RE, Yassine HN, Chen K. Duro MVV, et al. ACS Chem Neurosci. 2023 Dec 20;14(24):4409-4418. doi: 10.1021/acschemneuro.3c00681. Epub 2023 Dec 4. ACS Chem Neurosci. 2023. PMID: 38048230 Free PMC article.
Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study.
Conti M, Bolzacchini E, Luchena G, Bertu' L, Tagliabue P, Aglione S, Ardizzoia A, Arnoffi J, Guida FM, Bertolini A, Pastorini A, Duro M, Bettega D, Roda' G, Artale S, Squizzato A, Giordano M. Conti M, et al. Among authors: duro m. Cancers (Basel). 2023 Jul 2;15(13):3465. doi: 10.3390/cancers15133465. Cancers (Basel). 2023. PMID: 37444575 Free PMC article.
52 results